Organogenesis Holdings Inc. (ORGO)
USD 3.7
(-4.88%)
USD 3.7
(-4.88%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 60.74 Million USD | -43.52% |
| 2022 | 107.54 Million USD | -8.6% |
| 2021 | 117.66 Million USD | 82.46% |
| 2020 | 64.48 Million USD | -33.89% |
| 2019 | 97.54 Million USD | 98.21% |
| 2018 | 49.21 Million USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 57.73 Million USD | -2.76% |
| 2024 Q1 | 59.37 Million USD | -2.26% |
| 2023 Q4 | 60.74 Million USD | -41.09% |
| 2023 Q3 | 103.1 Million USD | -1.22% |
| 2023 FY | 60.74 Million USD | -43.52% |
| 2023 Q2 | 104.38 Million USD | -0.76% |
| 2023 Q1 | 105.18 Million USD | -2.19% |
| 2022 FY | 107.54 Million USD | -8.6% |
| 2022 Q4 | 107.54 Million USD | -2.75% |
| 2022 Q2 | 112.66 Million USD | -2.19% |
| 2022 Q3 | 110.58 Million USD | -1.85% |
| 2022 Q1 | 115.19 Million USD | -2.1% |
| 2021 Q4 | 117.66 Million USD | 21.67% |
| 2021 FY | 117.66 Million USD | 82.46% |
| 2021 Q1 | 74.42 Million USD | 15.41% |
| 2021 Q2 | 81.06 Million USD | 8.93% |
| 2021 Q3 | 96.7 Million USD | 19.29% |
| 2020 Q3 | 99.59 Million USD | -5.44% |
| 2020 FY | 64.48 Million USD | -33.89% |
| 2020 Q4 | 64.48 Million USD | -35.25% |
| 2020 Q2 | 105.31 Million USD | 0.16% |
| 2020 Q1 | 105.14 Million USD | 7.79% |
| 2019 FY | 97.54 Million USD | 98.21% |
| 2019 Q4 | 97.54 Million USD | -0.44% |
| 2019 Q3 | 97.97 Million USD | 11.59% |
| 2019 Q2 | 87.8 Million USD | 2.42% |
| 2019 Q1 | 85.72 Million USD | 74.19% |
| 2018 FY | 49.21 Million USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | 49.21 Million USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Journey Medical Corporation | 14.62 Million USD | -315.436% |
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | 80.384% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | 33.303% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 88.177% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -11169.213% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -11169.213% |
| SCYNEXIS, Inc. | 12.15 Million USD | -399.589% |
| Safety Shot Inc | 304.9 Thousand USD | -19822.468% |
| Alpha Teknova, Inc. | 13.25 Million USD | -358.418% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 87.602% |
| Bright Green Corporation | 201.78 Thousand USD | -30004.122% |
| Dynavax Technologies Corporation | 252.41 Million USD | 75.935% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | 87.888% |
| Cosmos Health Inc. | 3.03 Million USD | -1901.258% |
| PainReform Ltd. | 30 Thousand USD | -202383.333% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -51761.623% |
| Embecta Corp. | 1.62 Billion USD | 96.263% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | -355.838% |
| Procaps Group, S.A. | 28.41 Million USD | -113.816% |
| Theratechnologies Inc. | 51.26 Million USD | -18.501% |
| Harrow Health, Inc. | 183.17 Million USD | 66.837% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -69721.839% |
| Biofrontera Inc. | 804 Thousand USD | -7455.348% |
| DURECT Corporation | 2.7 Million USD | -2148.15% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | -82.989% |
| Cronos Group Inc. | 1.55 Million USD | -3796.408% |
| OptiNose, Inc. | 611 Thousand USD | -9841.899% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 87.81% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | -77.669% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -13250.549% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | -375.159% |
| Radius Health, Inc. | 339.66 Million USD | 82.116% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | -492.172% |
| Phibro Animal Health Corporation | 458.28 Million USD | 86.745% |
| Procaps Group S.A. | 28.41 Million USD | -113.816% |
| Alvotech | 1.02 Billion USD | 94.09% |
| TherapeuticsMD, Inc. | 6.53 Million USD | -829.96% |
| Viatris Inc. | 16.18 Billion USD | 99.625% |
| Rockwell Medical, Inc. | 8.29 Million USD | -632.485% |
| Aytu BioPharma, Inc. | 10.87 Million USD | -458.472% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -17979.353% |
| Tilray Brands, Inc. | 287.93 Million USD | 78.903% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | 49.593% |
| Shineco, Inc. | 10.01 Million USD | -506.399% |
| PetIQ, Inc. | 437.82 Million USD | 86.126% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 210 Thousand USD | -28826.19% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | 76.483% |
| Alimera Sciences, Inc. | 64.48 Million USD | 5.806% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 38.51 Million USD | -57.722% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -44866.652% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | -785.836% |
| Clever Leaves Holdings Inc. | 720 Thousand USD | -8336.806% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -270069.899% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | -85.424% |
| Hempacco Co., Inc. | 5.93 Million USD | -924.195% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.02 Billion USD | 94.09% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | -8.056% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 90.141% |
| Currenc Group, Inc. | 2.5 Million USD | -2323.041% |
| Kamada Ltd. | 7.43 Million USD | -716.685% |
| Indivior PLC | 235.66 Million USD | 74.224% |
| Evoke Pharma, Inc. | 5 Million USD | -1114.9% |
| Flora Growth Corp. | 942 Thousand USD | -6348.514% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -270069.899% |
| Evolus, Inc. | 120.35 Million USD | 49.53% |
| HUTCHMED (China) Limited | 48.18 Million USD | -26.056% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 89.69% |
| Akanda Corp. | 2.49 Million USD | -2332.568% |